Investment Rating - The report assigns a "Buy" rating for the company, HaiNeng Technology (920476) [1]. Core Insights - HaiNeng Technology has established a multi-product matrix through self-research and acquisitions, benefiting from the growth in the scientific instrument sector and increasing domestic market share [3][9]. - The company is focusing on a full industry chain model, which enhances its competitive barriers and ensures stable cash flow from its core products [3][9]. - The market for experimental analysis instruments is expected to grow significantly, with the Chinese market projected to reach $11.66 billion by 2029, driven by increasing domestic demand and a shift towards local production [9][53]. Summary by Sections 1. Company Overview - HaiNeng Technology, founded in 2006, specializes in the research, production, and sales of experimental analysis instruments, initially focusing on Kjeldahl nitrogen analyzers and microwave digestion instruments, and later expanding into chromatography instruments [15]. - The company has developed a diverse product range, including organic element analysis, sample preparation, chromatography, and general instruments, serving various sectors such as food, pharmaceuticals, and environmental testing [15]. 2. Market Potential - The global market for experimental analysis instruments is expected to grow from $82.95 billion in 2024 to $101.58 billion by 2029, with a compound annual growth rate (CAGR) of 4.10% [53][55]. - The Chinese market is anticipated to grow from $9.28 billion in 2024 to $11.66 billion by 2029, with a CAGR of 4.7% [53][55]. 3. Business Strategy - The company employs a multi-brand and multi-product strategy, focusing on high-value and technology-intensive products, particularly in the chromatography sector, which has shown significant growth potential [9][25]. - HaiNeng Technology has made strategic acquisitions to enhance its product offerings and market reach, including investments in companies that possess core technologies [9][15]. 4. Financial Projections - The company is projected to achieve total revenue of 3.79 billion yuan in 2025, with a net profit of 420 million yuan, reflecting a significant recovery in performance driven by increased demand in the pharmaceutical and renewable energy sectors [1][10]. - The earnings per share (EPS) is expected to rise from 0.15 yuan in 2024 to 0.49 yuan in 2025, indicating a strong rebound in profitability [1][10]. 5. Competitive Landscape - The experimental analysis instrument market is characterized by high barriers to entry, with significant competition from established international players, while domestic manufacturers are gradually increasing their market share through improved product quality and customer service [9][58].

Group 1 - The core viewpoint of the news is that Haineng Technology Group Co., Ltd. has released its 2025 performance forecast, indicating a significant increase in net profit compared to the previous year, driven by market demand recovery and growth in various sectors [1] - Haineng Technology expects to achieve a net profit attributable to shareholders of between 41 million to 44 million yuan in 2025, representing a year-on-year increase of 213.65% to 236.61% from 13.07 million yuan in the previous year [1] - The company anticipates a revenue of approximately 362 million yuan in 2025, reflecting a year-on-year growth of about 16.77%, with all product lines expected to contribute to this increase [1] Group 2 - Haineng Technology, established on November 29, 2006, specializes in analytical instruments and solutions for food safety and drug safety supervision, and is recognized as a national-level "little giant" enterprise [2] - As of January 16, 2026, Haineng Technology's stock closed at 24.35 yuan per share, up 2.44%, with a total market capitalization of approximately 2.074 billion yuan [2]

二、对公司的影响 本次对外捐赠是公司积极履行企业社会责任、践行可持续发展理念的实践 举措，资金来源于公司的自有资金，不影响公司正常业务开展及资金使用，对公 司当期及未来经营业绩不构成重大影响，不存在损害公司及中小股东利益的情 形。 特此公告。 证券代码：920476 证券简称：海能技术 公告编号：2026-003 海能未来技术集团股份有限公司 关于对外捐赠的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、对外捐赠事项概述 为支持国家教育事业的发展，海能未来技术集团股份有限公司（以下简称 "公司"）拟以自有资金向天津大学北洋教育发展基金会捐赠现金人民币 30.00 万元，捐赠款项将用于天津大学精密仪器与光电子工程学院曾周末实验室建设 和发展。公司通过本次捐赠，支持曾周末教授科研团队在基于神经网络和深度学 习的智能传感器和智能信号处理方向的研究发展，提升高端仪器产品的智能化 水平，培育支撑高端仪器产业发展的高素质人才。 根据《北京证券交易所股票上市规则》、《公司章程》等相关规定，本次捐赠 事项在董 ...

证券代码：920476 证券简称：海能技术 公告编号：2026-002 海能未来技术集团股份有限公司 第五届董事会第十二次临时会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2026 年 1 月 19 日 2.会议召开地点：山东省德州市临邑县花园东大街 16 号公司会议室 3.会议召开方式：现场结合通讯方式 4.发出董事会会议通知的时间和方式：2026 年 1 月 13 日以电子邮件方式发 出 5.会议主持人：董事长张振方先生 6.会议列席人员：高级管理人员 7.召开情况合法合规的说明： 本次会议的召集、召开、议案审议程序等符合有关法律、行政法规、部门规 章、规范性文件和《公司章程》的规定。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 董事刘文玉、臧恒昌、吕瑞敏、梁锦梅因外地办公原因以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于对外捐赠的议案》 1.议案内容： 为支持国家教育事业的发展 ...

Investment Rating - The report indicates a positive outlook for the industry, focusing on companies with expected performance improvements and high barriers to entry [2][3]. Core Insights - The report highlights that Lin Tai New Materials anticipates a net profit of 133.3 to 150.7 million yuan for 2025, representing a year-on-year increase of 64.48% to 85.95%, driven by stable sales in traditional automotive and rapid growth in hybrid vehicle components [3][6]. - Hai Neng Technology expects a net profit of 41 to 44 million yuan for 2025, with a significant year-on-year increase of 213.65% to 236.61%, attributed to overall market demand recovery and advancements in high-end instrument manufacturing [3][6]. - The report emphasizes the importance of focusing on companies with strong fundamentals and reasonable valuations, particularly those with expected performance improvements in 2025 [3][6]. Summary by Sections Performance Forecasts - Lin Tai New Materials projects a net profit of 133.3 to 150.7 million yuan for 2025, with growth driven by stable sales in traditional automotive and rapid growth in hybrid vehicle components [3][6]. - Hai Neng Technology forecasts a net profit of 41 to 44 million yuan for 2025, with growth driven by market demand recovery and advancements in high-end instruments [3][6]. Market Trends - The report notes that the North Exchange market is experiencing significant fluctuations, with the North Certificate 50 index declining by 3.6% [3][6]. - The overall PE ratio for North Exchange A shares has risen to 49X, indicating a recovery in market valuations [12][15]. Investment Opportunities - The report suggests focusing on three main areas for investment: companies with expected performance improvements, those related to service consumption, and companies in the new energy vehicle export chain [3][6]. - It highlights the potential for structural investment opportunities within the North Exchange, particularly in specialized and innovative enterprises [3][6].

Core Viewpoint - The A-share listed companies are gradually disclosing their performance forecasts for the year 2025, with a significant number of companies expecting substantial profit growth, driven by advancements in technology and market demand [1]. Group 1: Performance Forecasts - As of January 17, 2025, 365 listed companies have released their performance forecasts, with 138 companies expecting positive results [1]. - Longxin Bochuang (300548) anticipates a net profit of 320 million to 370 million yuan, representing a year-on-year growth of 344.01% to 413.39% [1]. - Shenghong Technology (300476) expects a net profit of 4.16 billion to 4.56 billion yuan, with a growth rate of 260.35% to 295.00% [4]. - Haitai Technology (301022) forecasts a net profit of 51.5 million to 66.8 million yuan, indicating a growth of 226.86% to 323.97% [8]. - Haineng Technology (920476) projects a net profit of 41 million to 44 million yuan, with a growth of 213.65% to 236.61% [16]. - Hongyuan Pharmaceutical (301246) expects a net profit of 113 million to 137 million yuan, reflecting a growth of 119.57% to 166.2% [17]. - Northern Rare Earth (600111) anticipates a net profit of 2.176 billion to 2.356 billion yuan, with an increase of 116.67% to 134.60% [20]. - Lishang Guochao (600738) forecasts a net profit of 14 million to 17 million yuan, indicating a growth of 92.96% to 134.31% [22]. - Cambridge Technology (603083) expects a net profit of 252 million to 278 million yuan, with a growth of 51.19% to 66.79% [25]. Group 2: Industry Trends - The demand for new generation information technologies such as cloud computing, artificial intelligence, and big data is driving the rapid growth of the data communication market, positively impacting companies' revenues and profits [1]. - Shenghong Technology is consolidating its technological leadership in the global PCB manufacturing sector, with high-end products achieving large-scale production, contributing to significant revenue growth [4]. - Haitai Technology benefits from a high industry boom and increasing orders due to the gradual release of production capacity from its initial public offering projects [8]. - Haineng Technology is experiencing growth in new materials, new energy, and pharmaceuticals, supported by overall market demand recovery [16]. - Northern Rare Earth has successfully increased its sales of lanthanum and cerium products, achieving significant inventory reduction and production growth [20].

Core Viewpoint - The article discusses the earnings forecasts for A-share listed companies in 2025, highlighting significant profit growth among several companies due to advancements in technology and market demand [2]. Group 1: Earnings Forecasts - As of January 17, 2025, 365 listed companies have released their earnings forecasts, with 138 companies expecting positive results [2]. - Notable companies such as Changxin Bochuang, Shenghong Technology, Haitai Technology, Haineng Technology, Hongyuan Pharmaceutical, and Northern Rare Earth are projected to achieve substantial profit increases [2]. Group 2: Company-Specific Forecasts - **Changxin Bochuang (300548)**: Expected net profit of 320 million to 370 million yuan, a year-on-year increase of 344.01% to 413.39%. Growth driven by demand for data communication products due to advancements in cloud computing and AI [2][4]. - **Shenghong Technology (300476)**: Anticipated net profit of 4.16 billion to 4.56 billion yuan, reflecting a growth of 260.35% to 295.00%. The company maintains a leading position in global PCB manufacturing, with high-end product sales driving revenue [5][8]. - **Haitai Technology (301022)**: Forecasted net profit of 51.5 million to 66.8 million yuan, a growth of 226.86% to 323.97%. Increased orders and capacity from new projects contribute to revenue growth [8][12]. - **Haineng Technology (920476)**: Expected net profit of 41 million to 44 million yuan, a rise of 213.65% to 236.61%. Growth attributed to market demand recovery and advancements in various sectors [12][13]. - **Hongyuan Pharmaceutical (301246)**: Projected net profit of 113 million to 137 million yuan, an increase of 119.57% to 166.20%. Growth driven by rising demand in the new energy vehicle and energy storage markets [14][16]. - **Northern Rare Earth (600111)**: Expected net profit of 2.176 billion to 2.356 billion yuan, a growth of 116.67% to 134.60%. Increased market expansion and improved product sales contribute to this growth [16]. - **Lishang Guochao (600738)**: Forecasted net profit of 14 million to 17 million yuan, an increase of 92.96% to 134.31%. Strategic adjustments have reduced losses from underperforming subsidiaries [18]. - **Jianqiao Technology (603083)**: Expected net profit of 252 million to 278 million yuan, a growth of 51.19% to 66.79%. Demand from AI and data center construction drives revenue growth [21].

Core Viewpoint - Haineng Technology (920476) announced a profit forecast for 2025, expecting a net profit of 41 million to 44 million yuan, representing a year-on-year growth of 213.65% to 236.61% [2] Group 1: Financial Performance - The expected net profit for 2025 is between 41 million and 44 million yuan [2] - The projected year-on-year growth rate is between 213.65% and 236.61% [2] Group 2: Stock Market Reaction - Haineng Technology's stock closed at 24.35 yuan, up 2.44%, with a turnover rate of 3.61% and a trading volume of 70.088 million yuan [2] - Over the past five days, the stock has increased by 3.00% [2] - Historical data shows that 68.33% of stocks with a profit forecast increase of over 50% saw a price increase on the announcement day, with 2 stocks hitting the daily limit [2] - 76.67% of stocks experienced price increases within five days following the profit forecast announcement [2]

Financial Performance - The company expects a net profit attributable to shareholders to be between 41 million to 44 million CNY, representing an increase of 213.65% to 236.61% compared to the same period last year, which was 13.07 million CNY[5] - Estimated operating revenue for the reporting period is approximately 362 million CNY, reflecting a year-on-year growth of about 16.77%[6] Market and Product Development - The growth in net profit is primarily driven by a recovery in market demand, significant trends in domestic high-end instrument manufacturing, and rapid growth in sectors such as new materials, new energy, and pharmaceuticals[6] - The company has maintained continuous investment in product research and development, market expansion, and brand enhancement, launching high-end instruments like organic element analyzers and liquid chromatographs[7] - The company has made significant progress in the intelligent and digital aspects of high-end instruments, leading to increased customer and market recognition, resulting in good revenue growth from related products[7] Operational Efficiency - The company has improved its digital management system and implemented lean management practices, significantly enhancing overall operational efficiency while maintaining stable gross profit margins[7] Financial Caution - The financial data presented is preliminary and unaudited, with investors advised to pay attention to investment risks[8]

Summary of Key Points Core Viewpoint - The trading volume and value of stocks on the Beijing Stock Exchange (BSE) saw a significant increase on January 9, with a total trading volume of 1.14 billion shares and a trading value of 29.886 billion yuan, marking an increase of 3.682 billion yuan compared to the previous trading day [1]. Trading Performance - A total of 202 stocks closed higher, representing 70.38% of the tradable stocks on the BSE, with notable gainers including Ge Li Er and Zhong Cheng Technology, which hit the daily limit up [1]. - The top gainers included Fuji Da, Hai Neng Technology, and Xing Tu Ce Kong, with increases of 9.47%, 7.95%, and 7.81% respectively [1]. - Conversely, 77 stocks closed lower, with Bei Yi Kang, Kai De Quartz, and Tian Li Composite showing the largest declines of 11.47%, 7.23%, and 6.18% respectively [1]. Trading Activity - There were 84 stocks with a trading value exceeding 10 million yuan, with Tian Li Composite, Fuji Da, and Xing Tu Ce Kong leading in trading value at 1.128 billion yuan, 1.051 billion yuan, and 1.037 billion yuan respectively [1]. - The trading activity was robust, with 44 stocks having a turnover rate exceeding 10%, and 10 stocks exceeding 20% [1]. Notable Stocks - The stock with the highest turnover rate was Zhong Cheng Technology at 35.49%, followed by Tian Run Technology at 28.04% and Da Peng Industrial at 27.70% [1]. - The trading details of several notable stocks were provided, highlighting their closing prices, percentage changes, turnover rates, and trading values [1][2][3][4][5][6][7][8][9][10].